O&G SAQs · Sexual & reproductive health
Abortion care — structured SAQ (15 marks)
FRANZCOG-format structured SAQ on first-trimester abortion care: counselling and assessment, the MS-2 Step regimen with gestational limits, method-specific analgesia and antibiotic prophylaxis, and the anti-D decision. Per-sub-part marking rubric included.
On this page
Study tools
Target exams
How this SAQ is marked
Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. Marks come from specifics: named drug, dose, route, limit, and the method-specific distinctions that examiners love. Write in short labelled points. [1]
Reveal model answer and mark schemeShowHide
(a) Counselling and pre-abortion assessment (4 marks)
One mark per point, maximum four. [1][6]
- Counsel the options: medical versus surgical, with the alternative of continuing the pregnancy and ongoing antenatal care, and adoption; give real numbers (medical failure roughly 4 to 8 percent; surgical completion over 99 percent); describe the bleeding, pain and follow-up timeline and the warning signs that mean return (soaking bleeding, severe pain, fever, fainting).[1]
- Structured history: last menstrual period and gestational estimate, prior caesarean or uterine surgery, allergies, anaemia, bleeding disorders, and contraception intentions.[1]
- Screen privately for reproductive coercion and intimate partner violence — red flags are a partner dominating the consult, patient discomfort, disruption in contraception use; use telehealth and discreet signals, plan covert care where safety demands.[6]
- Confirm gestational age (dates plus ultrasound where uncertain); note that routine haemoglobin and Rh D testing are not required before abortion up to 10 weeks, and that an asymptomatic woman with a confident gestational age does not need a confirmatory ultrasound (VEMA non-inferiority).[1][2]
(b) The MS-2 Step regimen and gestational limits (4 marks)
One mark each for regimen, dose/route, interval, and the limits. [1]
- Regimen: mifepristone 200 mg orally, then misoprostol 800 micrograms (four 200 microgram tablets) — the MS-2 Step pack (Linepharma mifepristone plus GyMiso misoprostol).[1]
- Route: buccal is the only approved route for misoprostol in Australia; sublingual and vaginal are alternatives in New Zealand.[1]
- Interval: misoprostol is taken 24 to 48 hours after the mifepristone.[1]
- Limits: licensed to 9 weeks (63 days) in Australia per TGA authorisation; used to 10 weeks (70 days) in Aotearoa New Zealand under jurisdictional protocols, with misoprostol off-label beyond 63 days.[1]
(c) Analgesia and antibiotic plan (4 marks)
Two marks analgesia, two marks antibiotic, with method separation. [1][4]
- Medical abortion analgesia: ibuprofen with an antiemetic 30 minutes before misoprostol is the first-line backbone; NSAIDs are first line, opioids as needed.[1]
- Surgical abortion analgesia: a multimodal bundle — buffered lidocaine paracervical block plus a preoperative NSAID (ibuprofen 600 mg lowers pain scores), with conscious or deep sedation or general anaesthesia for selected patients. Oral opioids do not reduce procedural pain.[4][1]
- Antibiotic — surgical: antibiotic prophylaxis for every woman having a surgical abortion, regimen per local protocol.[1][3]
- Antibiotic — medical: do not routinely give antibiotic prophylaxis for medical abortion up to 14 weeks (severe infection under 1 percent; over-use drives resistance); test-and-treat gonorrhoea and chlamydia on suspicion and screen those under 25.[1][3]
(d) Anti-D decision and counterpoint (3 marks)
One mark for the decision, one for the gestational reasoning, one for the counterpoint. [1][5]
- At 7 weeks 4 days (under 10 weeks) in an Rh D-negative woman, routine anti-D is not required before the abortion, and routine Rh D testing is not required before 10 weeks for either medical or surgical abortion.[1]
- Anti-D becomes recommended for abortion at 10 weeks or more in Rh D-negative women; below that there is no comparative evidence that it prevents sensitisation.[1][5]
- Counterpoint she should be aware of: guidelines from 2022 onwards, including the World Health Organization, now recommend against anti-D for first-trimester abortion entirely — a position examiners may probe and that local ANZ practice is moving toward.[5]
References6ShowHide
- [1]Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Clinical Guideline for Abortion Care (version 1.4) RANZCOG, Melbourne, 2026.Source
- [2]Brandell K, Jar-Allah T, Reynolds-Wright J, et al. Randomized Trial of Very Early Medication Abortion N Engl J Med, 2024.PMID 39504520
- [3]Cheng T, Kumar N, Laursen L, et al. Society of Family Planning Clinical Recommendation: Prevention of infection after abortion and pregnancy loss Contraception, 2025.PMID 40154660
- [4]Allen RH, Singh R Society of Family Planning clinical guidelines pain control in surgical abortion part 1 - local anesthesia and minimal sedation Contraception, 2018.PMID 29407363
- [5]Gemzell-Danielsson K, Cameron S, Bombas T, et al. Rhesus testing and anti-D prophylaxis in RhD-negative women undergoing first-trimester abortion-Systematic Review and Opinion Int J Gynaecol Obstet, 2026.PMID 40728267
- [6]Saldanha S, Botfield J, Mazza D Recognising and responding to reproductive coercion in general practice: a qualitative study BMJ Sex Reprod Health, 2026.PMID 41052903